Algen Biotechnologies

Algen Bio

United States · $5.4M raised

Employees
11–50
Business Model
B2B
Total Funding
$5.4M
Last Round
$5.4M Venture RoundNov 2024
Rounds
3

About

Algen Biotechnologies is a therapeutic drug discovery company decoding functional gene networks to develop safer, more effective treatments for cancer and inflammatory diseases. Founded by CEO Chun-Hao Huang, PhD (formerly of Jennifer Doudna's lab at UC Berkeley) and CBO Christine Du, MBA (Wharton), the company combines CRISPR-based functional genomics, single-cell analysis, and AI-driven models to identify disease-driving RNA targets and translate them into novel small-molecule and precision therapeutics.

Summary

Algen Biotechnologies is a Biotech company based in United States. It has raised $5.4M in total across 3 rounds, most recently a $5.4M Venture Round round in Nov 2024. Investors include Sequoia Capital, Cota Capital and Illumina Accelerator.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Venture RoundVenture RoundNov 2024

Sign up to see all 3 rounds

Seed through Venture Round — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Algen Biotechnologies on Indexed.vc
<a href="https://indexed.vc/companies/algen-biotechnologies"><img src="https://indexed.vc/api/badge/company/algen-biotechnologies" alt="Algen Biotechnologies on Indexed.vc" width="260" height="76" /></a>